Medicine
Orencia 125 mg/1 mL injection
Orencia 125 mg/1 mL injection is a prescription medicine containing Abatacept for subcutaneous use, marketed by ER Squibb & Sons, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Refrigerate ORENCIA lyophilized powder supplied in a vial at 2°C to 8°C (36°F…
Key facts
- Active ingredient (INN)
- Abatacept
- Brand
- Orencia
- Strength
- 125 mg/1 mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Packs
- 4 syringes of 1 mL
- Marketing authorisation holder
- ER Squibb & Sons
- Manufacturer
- ER Squibb & Sons
- Origin register
- US FDA, United States
- Storage
- Refrigerate ORENCIA lyophilized powder supplied in a vial at 2°C to 8°C (36°F to 46°F). Refrigerate ORENCIA solution supplied in a prefilled syringe or ClickJect autoinjector at 2°C to 8°C (36°F to 46°F). Do not allow the prefilled syringe or autoinjector to freeze. Protect from light by storing in the original package until time of use.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L04AA24 Abatacept
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 29 July 2011
- Identifiers
- RxCUI 616015, 616018, 1145929 +7DailyMed set ID 0836c6ac-ee37-5640-2fed-a3185a0b16ebNDC 0003-2188Application BLA125118
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 4 syringe, glass in 1 carton / 1 mL in 1 syringe, glass | 0003-2188-11 | ER Squibb & Sons | 1 October 2013 |
| 4 syringe, glass in 1 carton / 1 mL in 1 syringe, glass | 0003-2188-51 | ER Squibb & Sons | 7 June 2016 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Abatacept
Clinical summary
Abatacept is a selective T cell costimulation modulator indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA), among other approved uses. MedsAcross supplies Abatacept for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AbataceptFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ORENCIA prescribing information (ER Squibb & Sons) · U.S. National Library of Medicine, DailyMed
- Orencia: European public assessment report (EPAR) · European Medicines Agency
Need Orencia 125 mg/1 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.